DISPOSAL OF SUBSIDIARY (Details Narrative) ¥ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
|
Dec. 10, 2025
USD ($)
|
Dec. 10, 2025
CNY (¥)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
|
| Gain on disposal of subsidiary | $ 674,776 | $ 674,776 | ||
| Shandong Rongyuan Pharmaceuticals Co Ltd [Member] | ||||
| Aggregate consideration | $ 2,999,304 | ¥ 21.2 | ||
| Shandong Rngyuan Pharmaceutical Co. Ltd., [Member] | ||||
| Ownership percentage | 100.00% | 100.00% | ||
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|